Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skybiotech HealthcareBOM:512036 -0.30%23 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates BOM:512036 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 415 Conglomerates companies, Skybiotech Healthcare ranks worse than 240963.61% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Skybiotech Healthcare's
Operating Income
for the
three
months ended in Mar. 2026 was ₹-10.02 Mil. Skybiotech Healthcare's Interest Expense for the
three
months ended in Mar. 2026 was ₹-0.05 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Skybiotech Healthcare's Interest Coverage or its related term are showing as below:
BOM:512036's Interest Coverage is not ranked *
in the Conglomerates industry.
Industry Median: 5.54 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Skybiotech Healthcare Interest Coverage Related Terms
Skybiotech Healthcare Interest Coverage Historical Data
* Premium members only.
The historical data trend for Skybiotech Healthcare's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:512036 vs MMM, HON: Interest Coverage Comparison
For the Conglomerates subindustry, Skybiotech Healthcare's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skybiotech Healthcare Interest Coverage vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Skybiotech Healthcare's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Skybiotech Healthcare's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Skybiotech Healthcare did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Skybiotech Healthcare (BOM:512036) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Skybiotech Healthcare and its competitors. According to the industry distribution chart, Skybiotech Healthcare ranks #999999 out of 415 companies in the Conglomerates industry.
Is Skybiotech Healthcare's Interest Coverage too high?
Skybiotech Healthcare's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Skybiotech Healthcare ranks #999999 out of 415 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Skybiotech Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's Interest Coverage compare to MMM and HON?
According to the Conglomerates industry distribution chart, Skybiotech Healthcare ranks #999999 out of 415 companies for Interest Coverage. This places Skybiotech Healthcare in the lower half of its industry. The industry median Interest Coverage is 5.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Conglomerates company?
The median Interest Coverage among Conglomerates companies is 5.54, based on 415 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Skybiotech Healthcare and its competitors. For the Conglomerates industry, the median Interest Coverage is 5.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skybiotech Healthcare's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Skybiotech Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
23GF Score
Get the complete analysis for BOM:512036
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512036 has been successfully added to your 
